MARKET

STLN

STLN

Starling Oncology, Inc.
NASDAQ
6.94
+0.60
+9.46%
Pre Market: 6.94 0 0.00% 06:54 11/05 EST
OPEN
6.44
PREV CLOSE
6.34
HIGH
7.04
LOW
6.41
VOLUME
8
TURNOVER
0
52 WEEK HIGH
7.13
52 WEEK LOW
2.320
MARKET CAP
707.30M
P/E (TTM)
-22.7392
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STLN last week (1026-1030)?
Weekly Report · 3d ago
Weekly Report: what happened at STLN last week (1019-1023)?
Weekly Report · 10/26 10:12
Weekly Report: what happened at STLN last week (1012-1016)?
Weekly Report · 10/19 10:12
Analysts Offer Insights on Healthcare Companies: Starling Oncology Institute (STLN), Axsome Therapeutics (AXSM) and Contineum Therapeutics, Inc. Class A (CTNM)
TipRanks · 10/14 11:40
Starling Oncology Is Maintained at Buy by Needham
Dow Jones · 10/14 09:56
Starling Oncology Price Target Raised to $9.00/Share From $7.00 by Needham
Dow Jones · 10/14 09:56
Needham Maintains Buy on Starling Oncology, Raises Price Target to $9
Benzinga · 10/14 09:46
Weekly Report: what happened at STLN last week (1005-1009)?
Weekly Report · 10/12 10:17
More
About STLN
Starling Oncology, Inc., formerly The Oncology Institute, Inc., is advancing oncology by delivering specialized, value-based cancer care in the community setting. The Company offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with oncology organizations. Its critical services include cancer treatment and infusion centers, in-house dispensary, lab testing, outpatient blood transfusion, financial counseling, end-of-life counseling and comprehensive clinical trials. It treats many forms of cancer, including Acute lymphoblastic leukemia; Acute myeloid leukemia; Bladder cancer; Bone cancer; Brain cancer; Cervical cancer; Choriocarcinoma; Chronic lymphocytic leukemia (CLL); Chronic myeloid leukemia (CML); Skin cancer, and others. It operates over 100 clinics and affiliate locations across multiple states.

Webull offers Starling Oncology, Inc. stock information, including NASDAQ: STLN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STLN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STLN stock methods without spending real money on the virtual paper trading platform.